Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications

Cited by (1,003)

Items 701–800 of 1,003

  1. Phenotypic and functional alterations of myeloid‐derived suppressor cells during the disease course of multiple sclerosis
    Ellen Iacobaeus, Iyadh Douagi, Regina Jitschin, Maritha Marcusson‐Ståhl, Anton Törnqvist Andrén, Caroline Gavin, Katia Lefsihane, Lindsay C. Davies, Dimitrios Mougiakakos, Nadir Kadri et al. · 2018 · Immunology and Cell Biology
  2. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells
    Adriana M. Ledo, Maria Stella Sasso, Vincenzo Bronte, Ilaria Marigo, Ben J. Boyd, Marcos García-Fuentes, Marı́a José Alonso · 2018 · Journal of Controlled Release
  3. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
    Misagh Rajabinejad, Farhad Salari, Ali Gorgin Karaji, Alireza Rezaiemanesh · 2019 · Artificial Cells Nanomedicine and Biotechnology
  4. Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
    Shuiling Jin, Zhenzhen Yang, Xin Hao, Wenxue Tang, Wang Ma, Hong Zong · 2020 · Biomarker Research
  5. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis
    Xuezhen Zeng, Jingying Zhou, Zhewen Xiong, Hanyong Sun, Weiqin Yang, Myth T.S. Mok, Jing Wang, Jingqing Li, Man Liu, Wenshu Tang et al. · 2020 · Cellular and Molecular Immunology
  6. Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma
    Anne Blank, Irina Kremenetskaia, Ruth Maria Urbantat, Güliz Acker, Kati Turkowski, Josefine Radke, Ulf Christoph Schneider, Peter Vajkoczy, Susan Brandenburg · 2020 · The Journal of Pathology
  7. Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation
    Carolina Melero‐Jerez, Beatriz Fernández‐Gómez, Rafael Lebrón‐Galán, María Cristina Ortega, Irene Sánchez‐de Lara, Ana Cristina Ojalvo‐Sanz, Diego Clemente, Fernando de Castro · 2020 · Glia
  8. MDSCs, ageing and inflammageing
    Graham Pawelec, Emilie Picard, Valquíria Bueno, Chris P. Verschoor, Suzanne Ostrand‐Rosenberg · 2021 · Cellular Immunology
  9. Charting roadmaps towards novel and safe synergistic immunotherapy combinations
    Miguel F. Sanmamed, Pedro Berraondo, Maria Esperanza Rodriguez-Ruiz, Ignacio Melero · 2022 · Nature Cancer
  10. Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
    Robert H. Vonderheide, Adham Sean Bear · 2020 · Frontiers in Immunology
  11. The role of pyroptosis in modulating the tumor immune microenvironment
    Jinxiang Wu, Lei Wang, Jianwei Xu · 2022 · Biomarker Research
  12. Therapeutic prospects of targeting myeloid‐derived suppressor cells and immune checkpoints in cancer
    Salman M. Toor, Eyad Elkord · 2018 · Immunology and Cell Biology
  13. Expanding Neutrophil Horizons: New Concepts in Inflammation
    Simon M. Chatfield, Nathalie Thiéblemont, Véronique Witko‐Sarsat · 2018 · Journal of Innate Immunity
  14. SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
    Jonathan C. Poe, Wei Jia, Julie A. Di Paolo, Nancy Suyapa Reyes, Ji Yun Kim, Hsuan Su, John S. Sundy, Adela Rambi Cardones, Victor L. Perez, Benny J. Chen et al. · 2018 · JCI Insight
  15. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma
    Kim C. M. Santegoets, Paul R. Gielen, Christian Büll, Barbara M. Schulte, Esther D. Kers‐Rebel, Benno Küsters, Sandra A. J. F. H. Bossmann, Mark ter Laan, Pieter Wesseling, Gosse J. Adema · 2019 · Cancer Immunology Immunotherapy
  16. Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
    Carmen Salvador Coloma, Ana Santaballa, Elena Sanmartín, David C. Calvo, Ana García, David Hervás, Lourdes Cordón, Alfonso Quintás‐Cardama, Francisco Ripoll, Joaquín Panadero et al. · 2020 · European Journal of Cancer
  17. Immunosuppressive Myeloid Cells Induce Nitric Oxide–Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells
    Adam N.R. Cartwright, Shengbao Suo, Soumya Badrinath, Sushil Kumar, Johannes C. Melms, Adrienne Luoma, Archis Bagati, Assieh Saadatpour, Benjamin Izar, Guo‐Cheng Yuan et al. · 2021 · Cancer Immunology Research
  18. Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells
    Dominique Santos Rubenich, Natália Omizzollo, Mirosław J. Szczepański, Torsten E. Reichert, Theresa L. Whiteside, Nils Ludwig, Elizandra Braganhol · 2021 · Cytokine & Growth Factor Reviews
  19. Myeloid-derived suppressor cells are necessary for development of pulmonary hypertension
    Bryant, Andrew J., Shenoy, Vinayak, Fu, Chunhua, Marek, George, Lorentsen, Kyle J., Herzog, Erica L., Brantly, Mark L., Avram, Dorina, Scott, Edward W. · 2018 · American Journal of Respiratory Cell and Molecular Biology
  20. Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery
    Marisa Market, Gayashan Tennakoon, Rebecca C. Auer · 2021 · International Journal of Molecular Sciences
  21. MCP‑1 targeting: Shutting off an engine for tumor development (Review)
    Liang Wang, Jinxin Lan, Jiaping Tang, Na Luo · 2021 · Oncology Letters
  22. DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
    Adithya Gopinath, Phillip M. Mackie, Basil Hashimi, Anna Marie Buchanan, Aidan R. Smith, Rachel S. Bouchard, Gerry Shaw, Martin Badov, Leila Saadatpour, Aryn H. Gittis et al. · 2022 · npj Parkinson s Disease
  23. The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
    Evgeniy B. Eruslanov, Yulia Nefedova, Dmitry I. Gabrilovich · 2025 · Nature Immunology
  24. Macrophage Metabolism Shapes Angiogenesis in Tumors
    Alberto Mantovani, Massimo Locati · 2016 · Cell Metabolism
  25. Myeloid-derived suppressor cells and T regulatory cells in tumors: unraveling the dark side of the force
    Aikaterini Hatzioannou, Themis Alissafi, Panayotis Verginis · 2017 · Journal of Leukocyte Biology
  26. LncRNA RNCR3 promotes Chop expression by sponging miR-185-5p during MDSC differentiation
    Wencong Shang, Zhenzhen Tang, Yunhuan Gao, Houbao Qi, Lei Su, Yuan Zhang, Rongcun Yang · 2017 · Oncotarget
  27. Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease
    Margot Zöller · 2018 · Frontiers in Immunology
  28. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy
    Moshe Chaim Ornstein, Claudia Marcela Diaz-Montero, Patricia A. Rayman, Paul J. Elson, Samuel Haywood, James Harold Finke, Jin S. Kim, Paul G. Pavicic, Marcelo Lamenza, Sarah Devonshire et al. · 2018 · Urologic Oncology Seminars and Original Investigations
  29. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia
    Ho Namkoong, Makoto Ishii, Hideki Fujii, Kazuma Yagi, Takahiro Asami, Takanori Asakura, Shoji Suzuki, Ahmed E. Hegab, Hirofumi Kamata, Sadatomo Tasaka et al. · 2018 · PLoS Pathogens
  30. Tumor-specific macrophage targeting through recognition of retinoid X receptor beta
    Tang Tang, Yushuang Wei, Jinyoung Kang, Zhi‐Gang She, Dokyoung Kim, Michael J. Sailor, Erkki I. Ruoslahti, Hong‐Bo Pang · 2019 · Journal of Controlled Release
  31. Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
    Vera Petrova, Ihor Arkhypov, Rebekka Weber, Christopher Groth, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky · 2020 · International Journal of Molecular Sciences
  32. An emerging role for cellular crosstalk in the cancer stem cell niche
    Naoki Oshimori, Yifei Guo, Sachiko Taniguchi · 2021 · The Journal of Pathology
  33. Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
    Joo Youn Oh, Ryang Hwa Lee · 2021 · Progress in Retinal and Eye Research
  34. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome
    Rémy Coudereau, Louis Waeckel, Martin Cour, Thomas Rimmele, Rémi Pescarmona, Astrid Fabri, Laurent Jallades, Hodane Yonis, Morgane Gossez, Anne‐Claire Lukaszewicz et al. · 2021 · Journal of Leukocyte Biology
  35. Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy–Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression
    Nining Guo, Kaiyuan Ni, Taokun Luo, Guangxu Lan, Ainhoa Arina, Ziwan Xu, Jianming Mao, Ralph R. Weichselbaum, Michael T. Spiotto, Wenbin Lin · 2021 · ACS Nano
  36. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
    Igor Vladimirovich Kudryavtsev, Artem Rubinstein, А. С. Головкин, Olga Kalinina, Kirill Vasilyev, Руденко Лариса Георгиевна, Исакова-Сивак Ирина Николаевна · 2022 · Viruses
  37. Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils
    Massimo Russo, Claudia Nastasi · 2022 · Frontiers in Oncology
  38. Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity
    Bo Zhang, Jiaqi Sun, Yeshuang Yuan, Dezhong Ji, Yeting Sun, Yudong Liu, Shengjie Li, Xingxing Zhu, Xunyao Wu, Jin Hu et al. · 2023 · Signal Transduction and Targeted Therapy
  39. Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer
    Chikanori Tsutsumi, Kenoki Ohuchida, Naoki Katayama, Yutaka Yamada, Shoichi Nakamura, Sho Okuda, Yoshiki Otsubo, Chika Iwamoto, Nobuhiro Torata, Kohei Horioka et al. · 2024 · Gastric Cancer
  40. Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice
    Siwei Feng, Michael E. McNehlan, Rachel L. Kinsella, Chanchal Sur Chowdhury, Sthefany M. Chavez, Sumanta Kumar Naik, Samuel R. McKee, Jacob A. Van Winkle, Neha Dubey, Amanda N. Samuels et al. · 2024 · Nature Microbiology
  41. Neutrophils in cancer: dual roles through intercellular interactions
    Xinyu Yu, Changhui Li, Zijin Wang, Yaping Xu, Shiqun Shao, Fangwei Shao, Hua Wang, Jian Liu · 2024 · Oncogene
  42. Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Lingjun Wang, Haoyi Wang, Mingfang Zhu, Xiaofei Ni, Lu Sun, Wanru Wang, Jie Xie, Yubin Li, Yitong Xu, Ruting Wang et al. · 2024 · Blood
  43. Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells
    Jianxin Yang, Jacqueline D.H. Anholts, Ulrike Kolbe, Janine A. Stegehuis-Kamp, Frans H.J. Claas, Michael Eikmans · 2018 · International Journal of Molecular Sciences
  44. Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo
    Samantha Solito, Laura Pinton, Francesco De Sanctis, Stefano Ugel, Vincenzo Bronte, Susanna Mandruzzato, Ilaria Marigo · 2018 · Current Protocols in Immunology
  45. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond
    Amin Pastaki Khoshbin, Mahsa Eskian, Mahsa Keshavarz‐Fathi, Nima Rezaei · 2018 · Archivum Immunologiae et Therapiae Experimentalis
  46. RIPK3-Induced Inflammation by I-MDSCs Promotes Intestinal Tumors
    Asha Jayakumar, Alfred L.M. Bothwell · 2019 · Cancer Research
  47. PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation
    Nicola Tumino, Francesca Besi, Anna Laura Di Pace, Francesca Romana Mariotti, Pietro Merli, Giuseppina Li Pira, Federica Galaverna, Angela Pitisci, Tiziano Ingegnere, Andrea Pelosi et al. · 2019 · Leukemia
  48. Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
    Elodie Lauret Marie Joseph, Caroline Laheurte, Marine Jary, Laura Boullerot, Kamal Asgarov, Eléonore Gravelin, Adeline Bouard, Laurie Rangan, Magalie Dosset, Christophe Borg et al. · 2019 · Cancer Immunology Research
  49. Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development
    Sokchea Khou, Alexandra Popa, Carmelo Luci, Franck Bihl, Aïda Meghraoui, Pierre Bourdely, Emie Salavagione, Estelle Cosson, Alain Rubod, Julie Cazareth et al. · 2020 · Cancers
  50. Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
    Seiji Mabuchi, Tomoyuki Sasano, Naoko Komura · 2021 · Cells
  51. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment
    Juha P. Väyrynen, Koichiro Haruki, Sara A. Väyrynen, Mai Chan Lau, Andressa Dias Costa, Jennifer Borowsky, Melissa M. Zhao, Tomotaka Ugai, Junko Kishikawa, Naohiko Akimoto et al. · 2021 · Journal for ImmunoTherapy of Cancer
  52. Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
    James Harber, Tamihiro Kamata, Catrin A. Pritchard, Dean Anthony Fennell · 2021 · Journal for ImmunoTherapy of Cancer
  53. Regulatory Cells in Multiple Sclerosis: From Blood to Brain
    Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, María Cristina Ortega, Diego Clemente · 2022 · Biomedicines
  54. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer
    Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, Nilesh Deshpande, Long Cao, Siddharth Mehra, Samara P. Singh, Christine Isabelle Rafie, Xiaodian Sun, Xi Chen et al. · 2022 · Oncogene
  55. The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
    Group Young Researchers in Inflammatory Carcinogenesis, Anna Maxi Wandmacher, Anne‐Sophie Mehdorn, Susanne Sebens · 2021 · Cancers
  56. Complement activation in cancer: Effects on tumor-associated myeloid cells and immunosuppression
    Elena Illica Magrini, Luna Minute, Monica Dambra, Cecília Garlanda · 2022 · Seminars in Immunology
  57. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma
    Yewen Shi, Tongxin Xie, Bingbing Wang, Rong Wang, Yu Cai, Bo Yuan, Frederico O. Gleber‐Netto, Xiangjun Tian, Alanis Enid Rodriguez-Rosario, Abdullah A. Osman et al. · 2022 · Communications Biology
  58. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
    Heng‐Chung Kung, Jun Yu · 2023 · MedComm
  59. Immunosuppression in Sepsis: Biomarkers and Specialized Pro-Resolving Mediators
    Cristina M. Padovani, Kingsley Yin · 2024 · Biomedicines
  60. Immunotherapy resistance in solid tumors: mechanisms and potential solutions
    Daniel S. Lefler, Steven Anthony Manobianco, Babar Bashir · 2024 · Cancer Biology & Therapy
  61. Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies
    Saeed Daneshmandi, Jee Eun Choi, Yan Qi, Cameron R. MacDonald, Manu Raj Pandey, Mounika Goruganthu, Nathan T. Roberts, Prashant Kumar Singh, Richard M. Higashi, Andrew N. Lane et al. · 2024 · Nature Communications
  62. Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy
    Yafeng Qi, Liying Zhang, Yeyuan Liu, Yangyang Li, Yongqi Liu, Zhiming Zhang · 2024 · Biomedicine & Pharmacotherapy
  63. Targeting neutrophils for cancer therapy
    Jeff Kwak, A. McGarry Houghton · 2025 · Nature Reviews Drug Discovery
  64. Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice
    Melissa B. McPeak, Dima A. Youssef, Danielle A. Williams, Christopher L. Pritchett, Zhi Qiang Yao, Charles E. McCall, Mohamed El Gazzar · 2017 · Journal of Leukocyte Biology
  65. The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment
    Salem Chouaı̈b, Viktor Umansky, Claudine Kiéda · 2018 · Współczesna Onkologia
  66. Myeloid‐derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells
    Jiabin Ren, Weihong Zeng, Fu‐Ju Tian, Siming Zhang, Fan Wu, Xiaoli Qin, Yan Zhang, Yi Lin · 2019 · American Journal of Reproductive Immunology
  67. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules
    Laura Pinton, Sara Magri, Elena Masetto, Marina Vettore, Ilaria Schibuola, Vincenzo Ingangi, Ilaria Marigo, Kevin Matha, Jean‐Pierre Benoît, Alessandro Della Puppa et al. · 2020 · Journal of Nanobiotechnology
  68. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
    Carolina Melero‐Jerez, Aitana Alonso-Gómez, Esther Moñivas, Rafael Lebrón‐Galán, Isabel Machín-Díaz, Fernando de Castro, Diego Clemente · 2020 · Neurobiology of Disease
  69. Long noncoding RNA loss in immune suppression in cancer
    Qingsong Hu, Sergey D. Egranov, Chunru Lin, Liuqing Yang · 2020 · Pharmacology & Therapeutics
  70. The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation
    Ravikumar A. Sitapara, Alex G. Gauthier, Sergio Iván Valdés‐Ferrer, Mosi Lin, Vivek Patel, Mao Wang, Ashley T. Martino, Jeanette C. Perron, Charles R. Ashby, Kevin J. Tracey et al. · 2020 · Molecular Medicine
  71. Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer
    Ece Tavukçuoğlu, Utku Horzum, Hamdullah Yanık, Ayşegül Üner, Diğdem Yöyen-Ermiş, Safa Kürşat Nural, Busra Aydin, Cenk Sökmensüer, Derya Karakoç, Kerim Bora Yılmaz et al. · 2020 · European Journal of Immunology
  72. miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells
    Xingju Zhang, Fei Li, Ying Tang, Ren Qinglan, Bin Xiao, Ying Wan, Shan Jiang · 2020 · Oncogene
  73. The Anti-Inflammatory Role of Bilirubin on “Two-Hit” Sepsis Animal Model
    Duc Tin Tran, Yong Yeon Jeong, Jeongmin Kim, Hong Bum Bae, Sung Kuk Son, Sang Hyun Kwak · 2020 · International Journal of Molecular Sciences
  74. Role of immune regulatory cells in breast cancer: Foe or friend?
    Huanrong Lan, Wenlin Du, Yuyao Liu, Chunsen Mao, Ketao Jin, Xue Yang · 2021 · International Immunopharmacology
  75. IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies
    Baohuan Cai, Yun Liu, Yating Chong, Hualei Zhang, Atsuko Matsunaga, Xuexiu Fang, Rafał Pacholczyk, Gang Zhou, John Kenneth Cowell, Tianxiang Hu · 2021 · Molecular Cancer
  76. Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation
    Laurent Gorvel, Daniel Olive · 2022 · Seminars in Immunology
  77. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs
    Jing Wang, Ramón Ocádiz-Ruiz, Matthew S. Hall, Grace G. Bushnell, Sophia M. Orbach, Joseph T. Decker, Ravi M. Raghani, Yining Zhang, Aaron H. Morris, Jacqueline Sara Jeruss et al. · 2023 · Nature Communications
  78. Myeloid‐derived suppressor cells mediate tolerance induction in autoimmune disease
    Anja Wegner, Johan Verhagen, David Cameron Wraith · 2017 · Immunology
  79. Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients
    Atsushi Mitsuhashi, Yusuke Okuma · 2018 · Clinical & Translational Oncology
  80. Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac Repair
    Ingrid Gomez, Vincent Duval, Jean‐Sébastien Silvestre · 2018 · Frontiers in Cardiovascular Medicine
  81. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma
    Miao‐Fen Chen, Ping‐Tsung Chen, Feng‐Che Kuan, Wen‐Cheng Chen · 2018 · Annals of Surgical Oncology
  82. Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer
    Sabrina H. L. Hoffmann, Dorothea I. Reck, Andreas Maurer, Birgit Fehrenbacher, Jaclyn Sceneay, Marilena Poxleitner, Hasan Halit Öz, Walter Ehrlichmann, Gerald Reischl, Kerstin Fuchs et al. · 2019 · Theranostics
  83. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus
    Anca Dorhoi, Leigh A. Kotzé, Jay A. Berzofsky, Yongjun Sui, Dmitry I. Gabrilovich, Ankita Garg, Richard Hafner, Shabaana A. Khader, Ulrich Emil Schaible, Stefan H. E. Kaufmann et al. · 2020 · Journal of Clinical Investigation
  84. Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment
    Vitaliy Davidov, Garrett L. Jensen, Sunny Mai, Shu‐Hsia Chen, Ping‐Ying Pan · 2020 · Frontiers in Immunology
  85. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
    Hernán F. Peñaloza, Janet S. Lee, Prabir Ray · 2021 · PLoS Pathogens
  86. Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells
    Jingshan Cai, Yudan Cui, Jun Yang, Shengjun Wang · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  87. Association between periodontitis and inflammatory comorbidities: The common role of innate immune cells, underlying mechanisms and therapeutic targets
    Qibing Wu, Weijia Zhang, Yaqiong Lu, Hongxia Li, Yaru Yang, Fengxue Geng, Jinwen Liu, Lin Li, Yaping Pan, Chen Li · 2024 · International Immunopharmacology
  88. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2
    Ronja Wieboldt, Michael T. Sandholzer, Emanuele Carlini, Chia‐Wei Lin, Anastasiya Börsch, Andreas Zingg, Didier Lardinois, Petra Herzig, Leyla Don, Alfred Zippelius et al. · 2024 · Cellular and Molecular Immunology
  89. Expansion and activation of granulocytic, myeloid-derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia
    Yufeng Liu, Yingying Chen, Yingyi He, Jiayi Wang, Jian-ping Yang, Shuling Zhong, Nan Jiang, Pan Zhou, Hua Jiang, Jie Zhou · 2017 · Journal of Leukocyte Biology
  90. Immunotherapy for Breast Cancer: Current and Future Strategies
    Austin David Williams, Kyle K. Payne, Avery D. Posey, Christine Hill, Jose Ramon Conejo-Garcia, Carl H. June, Julia C. Tchou · 2017 · Current Surgery Reports
  91. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
    Min Li, Dongwei Zhu, Tingting Wang, Xueli Xia, Jie Tian, Shengjun Wang · 2018 · Frontiers in Immunology
  92. Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-ResistantKlebsiella pneumoniaeSequence Type 258 by Enhancing Its Clearance in the Airways
    Hernán F. Peñaloza, Loreani P. Noguera, Danielle S. Ahn, Omar P. Vallejos, Raquel M. Castellanos, Yaneisi Vázquez, Francisco J. Salazar‐Echegarai, Liliana A González, Isidora D. Suazo, Catalina Pardo‐Roa et al. · 2019 · Infection and Immunity
  93. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
    Robert G. Brenig, Oltin T. Pop, Evangelos Triantafyllou, Anne Geng, Arjuna Singanayagam, Christian Perez‐Shibayama, Lenka Bešše, Jovana Cupovic, Patrizia Künzler‐Heule, Tuyana Boldanova et al. · 2019 · Life Science Alliance
  94. Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
    Shumin Li, Chengyan Zhang, Guanchao Pang, Pingli Wang · 2020 · Frontiers in Immunology
  95. Zebrafish Models for the Safety and Therapeutic Testing of Nanoparticles with a Focus on Macrophages
    Alba Pensado‐López, Juan Fernández-Rey, Pedro Reimunde, José Crecente‐Campo, Laura E. Sanchez, Fernando Torres · 2021 · Nanomaterials
  96. Amino Acid Transport and Metabolism in Myeloid Function
    Marie Jo Halaby, Tracy L. McGaha · 2021 · Frontiers in Immunology
  97. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled
    Ronit Vogt Sionov · 2021 · Cells
  98. 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
    Saeed Daneshmandi, Teresa Cassel, Richard M. Higashi, Teresa W.‐M. Fan, Pankaj Seth · 2021 · eLife
  99. Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19
    Elisa Brauns, Abdulkader Azouz, David Grimaldi, Hanxi Xiao, Séverine Thomas, Muriel Nguyen, Véronique Olislagers, Inès Vu Duc, Carmen Orte Cano, V. del Mármol et al. · 2022 · JCI Insight
  100. Immune Response to Persistent Staphyloccocus Aureus Periprosthetic Joint Infection in a Mouse Tibial Implant Model
    Upneet K. Sokhi, Yunwei Xia, Branden R. Sosa, Kathleen Turajane, Sita Nirupama Nishtala, Tania Pannellini, Mathias P. Bostrom, Alberto V. Carli, Xu Yang, Lionel B. Ivashkiv · 2020 · Journal of Bone and Mineral Research